Carri Geer - Novan Senior Vice President and CTO

NOVNDelisted Stock  USD 0.03  0.01  33.46%   

President

Mr. W. Kent Geer is a Independent Director of the Company. He has served as a member of our board of directors since 2015. Mr. Geer was an audit partner with Ernst Young LLP from 1989 to 2011. Beginning in 2012, Mr. Geer served as the Chairman of the board of directors of PowerSecure International, Inc. until the successful sale of the company in May 2016. since 2015.
Age 61
Tenure 9 years
Professional MarksPh.D
Phone919 485 8080
Webhttps://www.novan.com
Geer has a Ph.D. in Chemistry from the University of North Carolina where she was a doctoral student and part of the Schoenfisch Lab, led by Novan cofounder.

Novan Management Efficiency

The company has return on total asset (ROA) of (0.2584) % which means that it has lost $0.2584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.9889) %, meaning that it created substantial loss on money invested by shareholders. Novan's management efficiency ratios could be used to measure how well Novan manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 3.93 M in liabilities with Debt to Equity (D/E) ratio of 4.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novan Inc has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Novan until it has trouble settling it off, either with new capital or with free cash flow. So, Novan's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Novan Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Novan to invest in growth at high rates of return. When we think about Novan's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

PRESIDENT Age

Michael TeifelAeterna Zentaris
N/A
Bonne AdamsTRACON Pharmaceuticals
47
Stephen MachathaAldeyra
47
Massimo MBAJaguar Animal Health
66
Novan, Inc., a medical dermatology company, focuses on researching, developing, and commercializing therapeutic products for skin diseases. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Novan operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people. Novan Inc (NOVN) is traded on NASDAQ Exchange in USA and employs 90 people.

Management Performance

Novan Inc Leadership Team

Elected by the shareholders, the Novan's board of directors comprises two types of representatives: Novan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novan. The board's role is to monitor Novan's management team and ensure that shareholders' interests are well served. Novan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novan's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paula MPH, CEO Pres
John Donofrio, COO VP
Carri Geer, Senior Vice President and CTO
JD BS, VP RD
Brian Johnson, Chief Commercial Officer
Andrew Novak, Vice President Chief Accounting Officer and Principal Accounting Officer
MBA MD, Chief Officer
Cole Ikkala, Communications Relations
John CPA, CFO Sec

Novan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Novan Stock

If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules